BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37211089)

  • 1. Pathologically diagnosed placenta accreta spectrum without placenta previa: a systematic review and meta-analysis.
    Sugai S; Yamawaki K; Sekizuka T; Haino K; Yoshihara K; Nishijima K
    Am J Obstet Gynecol MFM; 2023 Aug; 5(8):101027. PubMed ID: 37211089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of maternal outcomes and clinical characteristics of prenatally vs nonprenatally diagnosed placenta accreta spectrum: a systematic review and meta-analysis.
    Sugai S; Yamawaki K; Sekizuka T; Haino K; Yoshihara K; Nishijima K
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101197. PubMed ID: 37865220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal-occult placenta accreta: a clandestine source of maternal morbidity.
    Larish A; Horst K; Brunton J; Schenone M; Branda M; Mehta R; Packard A; VanBuren W; Norgan A; Shahi M; Missert A; Pompeian R; Greenwood J; Theiler R
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100924. PubMed ID: 36934974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis.
    Jauniaux E; Bhide A
    Am J Obstet Gynecol; 2017 Jul; 217(1):27-36. PubMed ID: 28268196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Correlates of Placenta Accreta Spectrum Disorder Depending on the Presence or Absence of Placenta Previa: A Systematic Review and Meta-analysis.
    Hessami K; Salmanian B; Einerson BD; Carusi DA; Shamshirsaz AA; Shainker SA; Subramaniam A; Shrivastava VK; Nieto-Calvache AJ; Gilner JB; Khandelwal M; Backer-Meurke S; Cimic A; Aalipour S; Grace MR; Fox KA; Lyell DJ; Belfort MA; Silver RM; Shamshirsaz AA
    Obstet Gynecol; 2022 Oct; 140(4):599-606. PubMed ID: 36075058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta Accreta Spectrum Without Placenta Previa.
    Carusi DA; Fox KA; Lyell DJ; Perlman NC; Aalipour S; Einerson BD; Belfort MA; Silver RM; Shamshirsaz AA
    Obstet Gynecol; 2020 Sep; 136(3):458-465. PubMed ID: 32769646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro fertilization as an independent risk factor for placenta accreta spectrum.
    Salmanian B; Fox KA; Arian SE; Erfani H; Clark SL; Aagaard KM; Detlefs SE; Aalipour S; Espinoza J; Nassr AA; Gibbons WE; Shamshirsaz AA; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2020 Oct; 223(4):568.e1-568.e5. PubMed ID: 32360847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis on placenta accreta spectrum disorders in twin pregnancies: risk factors, detection rate and histopathology.
    DI Girolamo R; Buca D; Galliani C; D'Amico A; CALì G; Lucidi A; Giannini C; Chiarelli F; Liberati M; D'Antonio F
    Minerva Obstet Gynecol; 2023 Feb; 75(1):55-61. PubMed ID: 34328297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 11. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center.
    Varlas VN; Bors RG; Birsanu S; Maxim B; Clotea E; Mihailov M
    J Med Life; 2021; 14(3):367-375. PubMed ID: 34377203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes associated with peripartum hysterectomy in the setting of placenta accreta spectrum disorder.
    Overton E; Wen T; Friedman AM; Azad H; Nhan-Chang CL; Booker WA; Khoury-Collado F; Mourad M
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101174. PubMed ID: 37802412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa.
    Mulla BM; Weatherford R; Redhunt AM; Modest AM; Hacker MR; Hecht JL; Spiel MH; Shainker SA
    Arch Gynecol Obstet; 2019 Dec; 300(6):1601-1606. PubMed ID: 31691015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of transvaginal ultrasound in the third-trimester evaluation of patients at high risk of placenta accreta spectrum at birth.
    Jauniaux E; Hussein AM; Thabet MM; Elbarmelgy RM; Elbarmelgy RA; Jurkovic D
    Am J Obstet Gynecol; 2023 Oct; 229(4):445.e1-445.e11. PubMed ID: 37187303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of placenta accreta spectrum at vaginal birth after cesarean delivery.
    Matsuzaki S; Rau AR; Mandelbaum RS; Tavakoli A; Mazza GR; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol MFM; 2023 Oct; 5(10):101115. PubMed ID: 37543142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect prophylactic internal iliac artery balloon occlusion in patients with placenta previa or placental accreta spectrum: a systematic review and meta-analysis.
    Nankali A; Salari N; Kazeminia M; Mohammadi M; Rasoulinya S; Hosseinian-Far M
    Reprod Biol Endocrinol; 2021 Mar; 19(1):40. PubMed ID: 33663536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and clinical outcomes for placenta accreta spectrum with or without placenta previa.
    Ogawa K; Jwa SC; Morisaki N; Sago H
    Arch Gynecol Obstet; 2022 Mar; 305(3):607-615. PubMed ID: 34448037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of placenta previa accreta: a systematic review and meta-analysis.
    Jauniaux E; Grønbeck L; Bunce C; Langhoff-Roos J; Collins SL
    BMJ Open; 2019 Nov; 9(11):e031193. PubMed ID: 31722942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.